Neonatal Stem Cell Transplantation

There are substantial advances in baby treatment over the past two decades that have resulted within the exaggerated survival of terribly low birth weight infants, survival that in some centers extends to 22 weeks gestational age. Despite these advances, there continues to be significant morbidity associated with extreme preterm birth that includes both short-term and long-term pulmonary and neurologic consequences. No single medical care has evidenced to be effective in preventing or treating either organic process respiratory organ and brain injuries in preterm infants or the hypoxic-ischemic injury that may be inflicted on the full-term  brain as a results of in utero or perinatal complications. Stem cell–based therapies ar rising as a possible paradigm-shifting approach for such complicated diseases with complex etiologies, but a great deal of work is still required to understand the role of stem/progenitor cells in traditional development and within the repair of burned tissue.


    Related Conference of Neonatal Stem Cell Transplantation

    October 23-24, 2020

    Materials Electrochemistry Conference: Advancements and Breakthroughs

    Cape Town, South Africa
    November 09-10, 2020

    12th World Congress on Biopolymers and Biomaterials

    Amsterdam, Netherlands
    November 11-12, 2020

    4th Global Meet on Materials Science and Nano Materials

    Paris, France
    November 19-20, 2020

    3rd International Conference on Materials Science & Research

    Budapest, Hungary
    November 23-24, 2020

    27th International Conference on Advanced Materials

    Edinburgh, Scotland
    December 07-08, 2020

    2nd World Brain Congress

    Dubai, UAE

    Neonatal Stem Cell Transplantation Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in